News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
764,220 Results
Type
Article (71241)
Company Profile (320)
Press Release (692659)
Multimedia
Podcasts (131)
Webinars (14)
Section
Business (209864)
Career Advice (3414)
Deals (38861)
Drug Delivery (129)
Drug Development (85545)
Employer Resources (188)
FDA (17430)
Job Trends (16811)
News (364062)
Policy (37213)
Tag
Academia (2999)
Academic (1)
Accelerated approval (6)
Adcomms (29)
Allergies (96)
Alliances (51583)
ALS (104)
Alzheimer's disease (1504)
Antibody-drug conjugate (ADC) (162)
Approvals (17386)
Artificial intelligence (308)
Autoimmune disease (29)
Automation (16)
Bankruptcy (384)
Best Places to Work (12587)
BIOSECURE Act (22)
Biosimilars (120)
Biotechnology (225)
Bladder cancer (85)
Brain cancer (31)
Breast cancer (312)
Cancer (2479)
Cardiovascular disease (210)
Career advice (2892)
Career pathing (34)
CAR-T (176)
Cell therapy (489)
Cervical cancer (22)
Clinical research (69346)
Collaboration (935)
Company closure (2)
Compensation (577)
Complete response letters (30)
COVID-19 (2867)
CRISPR (50)
C-suite (275)
Cystic fibrosis (109)
Data (2360)
Decentralized trials (2)
Denatured (46)
Depression (56)
Diabetes (302)
Diagnostics (6914)
Digital health (20)
Diversity (9)
Diversity, equity & inclusion (43)
Drug discovery (130)
Drug pricing (130)
Drug shortages (33)
Duchenne muscular dystrophy (104)
Earnings (85717)
Editorial (47)
Employer branding (24)
Employer resources (159)
Events (118539)
Executive appointments (788)
FDA (18851)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (9)
Funding (823)
Gene editing (125)
Generative AI (28)
Gene therapy (361)
GLP-1 (859)
Government (5138)
Grass and pollen (6)
Guidances (150)
Healthcare (20873)
Huntington's disease (26)
IgA nephropathy (31)
Immunology and inflammation (152)
Indications (30)
Infectious disease (3030)
Inflammatory bowel disease (159)
Inflation Reduction Act (11)
Influenza (57)
Intellectual property (102)
Interviews (657)
IPO (17558)
IRA (51)
Job creations (4661)
Job search strategy (2370)
Kidney cancer (11)
Labor market (45)
Layoffs (563)
Leadership (24)
Legal (9224)
Liver cancer (82)
Lung cancer (349)
Lymphoma (161)
Machine learning (9)
Management (63)
Manufacturing (363)
MASH (81)
Medical device (14612)
Medtech (14617)
Mergers & acquisitions (21890)
Metabolic disorders (806)
Multiple sclerosis (89)
NASH (23)
Neurodegenerative disease (116)
Neuropsychiatric disorders (34)
Neuroscience (2119)
NextGen: Class of 2025 (7479)
Non-profit (5080)
Now hiring (41)
Obesity (433)
Opinion (272)
Ovarian cancer (83)
Pain (105)
Pancreatic cancer (91)
Parkinson's disease (162)
Partnered (24)
Patents (258)
Patient recruitment (119)
Peanut (51)
People (60342)
Pharmaceutical (66)
Pharmacy benefit managers (22)
Phase I (21452)
Phase II (30202)
Phase III (22931)
Pipeline (1397)
Policy (180)
Postmarket research (3089)
Preclinical (9208)
Press Release (69)
Prostate cancer (114)
Psychedelics (38)
Radiopharmaceuticals (269)
Rare diseases (436)
Real estate (6492)
Recruiting (74)
Regulatory (25216)
Reports (48)
Research institute (2645)
Resumes & cover letters (539)
Rett syndrome (5)
RNA editing (5)
RSV (50)
Schizophrenia (82)
Series A (144)
Series B (94)
Service/supplier (14)
Sickle cell disease (59)
Special edition (20)
Spinal muscular atrophy (163)
Sponsored (34)
Startups (3975)
State (2)
Stomach cancer (16)
Supply chain (75)
Tariffs (54)
The Weekly (83)
Vaccines (822)
Venture capitalists (45)
Weight loss (305)
Women's health (41)
Worklife (20)
Date
Today (36)
Last 7 days (981)
Last 30 days (3208)
Last 365 days (34481)
2025 (12517)
2024 (37487)
2023 (42556)
2022 (53925)
2021 (58717)
2020 (57658)
2019 (51306)
2018 (39090)
2017 (35766)
2016 (35438)
2015 (44074)
2014 (39633)
2013 (34282)
2012 (30066)
2011 (30656)
2010 (29100)
Location
Africa (1112)
Alabama (59)
Alaska (7)
Arizona (217)
Arkansas (14)
Asia (45472)
Australia (7838)
California (6620)
Canada (2100)
China (573)
Colorado (283)
Connecticut (298)
Delaware (161)
Europe (105190)
Florida (975)
Georgia (225)
Hawaii (1)
Idaho (62)
Illinois (602)
India (28)
Indiana (335)
Iowa (10)
Japan (177)
Kansas (112)
Kentucky (27)
Louisiana (13)
Maine (70)
Maryland (978)
Massachusetts (5004)
Michigan (246)
Minnesota (423)
Mississippi (2)
Missouri (91)
Montana (31)
Nebraska (26)
Nevada (69)
New Hampshire (69)
New Jersey (1861)
New Mexico (31)
New York (1865)
North Carolina (1105)
North Dakota (9)
Northern California (2875)
Ohio (221)
Oklahoma (15)
Oregon (40)
Pennsylvania (1451)
Puerto Rico (14)
Rhode Island (33)
South America (1495)
South Carolina (26)
South Dakota (1)
Southern California (2481)
Tennessee (107)
Texas (973)
United States (25071)
Utah (199)
Virginia (163)
Washington D.C. (71)
Washington State (590)
West Virginia (3)
Wisconsin (66)
764,220 Results for "ac immune sa".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
AC Immune Reports First Quarter 2025 Financial Results and Provides a Corporate Update
May 1, 2025
·
9 min read
Press Releases
AC Immune to Participate in Upcoming Investor Conferences
March 4, 2025
·
3 min read
Press Releases
AC Immune Announces Upcoming Presentations and Industry Symposium on Active Immunotherapies at AD/PD™ 2025
March 26, 2025
·
5 min read
Press Releases
AC Immune Reports Full Year 2024 Financial Results and Provides a Corporate Update
March 13, 2025
·
14 min read
AC Immune to Present at the Jefferies Global Healthcare Conference in June 2024
AC Immune SA announced that Company Management will participate in a fireside chat and one-on-one investor meetings during the Jefferies 2024 Global Healthcare Conference, taking place in-person in New York on June 5-6, 2024.
May 28, 2024
·
3 min read
Genetown
AC Immune and Takeda Sign Exclusive Option and License Agreement for Active Immunotherapy Targeting Amyloid Beta for Alzheimer’s Disease
Takeda and AC Immune SA announced an exclusive, worldwide option and license agreement for AC Immune’s active immunotherapies targeting toxic forms of amyloid beta, including ACI-24.060 for the treatment of Alzheimer’s disease.
May 13, 2024
·
12 min read
Press Releases
AC Immune Reports Further Positive Interim Results from Phase 2 Trial of ACI-7104.056 Active Immunotherapy in Early Parkinson’s Disease
April 2, 2025
·
5 min read
Business
AC Immune Reports First Quarter 2024 Financial Results and Provides a Corporate Update
AC Immune SA, a clinical-stage biopharmaceutical company pioneering the development of precision medicine approaches for the diagnosis, treatment, and prevention of neurodegenerative diseases, reported results for the quarter ended March 31, 2024, and provided a corporate update.
May 13, 2024
·
9 min read
Business
AC Immune SA Appoints New Chief Medical Officer
AC Immune SA, a clinical-stage biopharmaceutical company pioneering precision medicine for neurodegenerative diseases, announced the appointment of Nuno Mendonça, MD.
July 26, 2023
·
5 min read
AC Immune Announces Upcoming Presentations at AD/PD™ 2024
AC Immune SA announced upcoming presentations highlighting its precision medicine pipeline at the International Conference on Alzheimer’s and Parkinson’s Diseases, taking place in Lisbon, Portugal March 5-9, 2024.
February 22, 2024
·
5 min read
1 of 76,422
Next
